Redwood City, CA, United States of America

Jason Burch

USPTO Granted Patents = 13 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 79(Granted Patents)

Location History:

Westmount, CA (2011 - 2015)
Redwood City, CA (US) (2013 - 2018)

Company Filing History:

Merck Sharp + Dohme Corp.

Merck Frosst Canada, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2018

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9931323 - Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2018-04-03),

2. 9605005 - Alkynyl alcohols and methods of use (2017-03-28),

3. 9487504 - Imidazolyl analogs as syk inhibitors (2016-11-08),

4. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors (2016-06-28),

5. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors (2016-05-31),

6. 9328106 - Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2016-05-03),

7. 8969394 - Thiophenecarboxamide derivatives as EP4 receptor ligands (2015-03-03),

8. 8735417 - Aminopyrimidines as Syk inhibitors (2014-05-27),

9. 8685999 - Beta carboline sulphonylurea derivatives as EP4 receptor antagonists (2014-04-01),

10. 8551984 - Aminopyrimidines as SYK inhibitors (2013-10-08),

11. 8486975 - Non-nucleoside reverse transcriptase inhibitors (2013-07-16),

12. 8013159 - Quinoline derivatives as EP4 antagonists (2011-09-06),

13. 8003661 - Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists (2011-08-23),

Title: Jason Burch: Innovator in Pharmaceutical Compounds

Introduction

Jason Burch is a prominent inventor based in Redwood City, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in cancer treatment. With a total of 13 patents to his name, Burch's work is recognized for its potential impact on medical therapies.

Latest Patents

Among his latest patents, Burch has developed cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. These compounds are designed to inhibit Pim kinase, which plays a crucial role in various cancers. The patents detail the use of these compounds for diagnosing, preventing, or treating disorders mediated by Pim kinase in mammalian cells. Additionally, he has patented alkynyl alcohols and methods of use, further showcasing his innovative approach to pharmaceutical development.

Career Highlights

Burch has worked with notable companies in the pharmaceutical industry, including Merck Canada Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to refine his expertise in drug development and patenting innovative compounds.

Collaborations

Throughout his career, Jason Burch has collaborated with esteemed colleagues such as Alan B Northrup and Michael D Altman. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Jason Burch stands out as a significant figure in the realm of pharmaceutical innovations. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.